Da Cheng

机构：Central South University · ORCID：0000-0002-4078-3092

发表论文 37 篇 · 总被引 344 次 · h-index 8

代表论文

• Hepatic macrophages: Key players in the development and progression of liver fibrosis (2021 · Liver International · 被引 191)
• Oral Enrichment of Streptococcus and its Role in Systemic Inflammation Related to Monocyte Activation in Humans with Cocaine Use Disorder (2021 · Journal of Neuroimmune Pharmacology · 被引 24)
• Efficacy and Economic Evaluation of Nonbiological Artificial Liver Therapy in Acute-on-chronic Hepatitis B Liver Failure (2022 · Journal of Clinical and Translational Hepatology · 被引 22)
• Hepatic BRD4 Is Upregulated in Liver Fibrosis of Various Etiologies and Positively Correlated to Fibrotic Severity (2021 · Frontiers in Medicine · 被引 19)
• Tenofovir alafenamide versus entecavir for treating hepatitis B virus-related acute-on-chronic liver failure: real-world study (2023 · Frontiers in Microbiology · 被引 18)
• METTL3 inhibition ameliorates liver damage in mouse with hepatitis B virus-associated acute-on-chronic liver failure by regulating miR-146a-5p maturation (2021 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · 被引 17)